References
- Pai M, Kunimoto D, Jamieson F, Menzies D. Diagnosis of latent tuberculosis infection. In: D. Menzies ed. Canadian Tuberculosis Standards, 7th ed. Ottawa, Canada: Public Health Agency of Canada; Canadian Thoracic Society; 2014, Chp 4.
- Greenaway C, Khan K, Schwartzman K. Tuberculosis surveillance and screening in selected high-risk populations. In: D. Menzies ed. Canadian Tuberculosis Standards, 7th ed. Ottawa, Canada: Public Health Agency of Canada; Canadian Thoracic Society; 2014, Chp 13.
- ATS/CDC Standards. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:s221–s247, p s225. doi:10.1164/ajrccm.161.supplement_3.ats600. PMID:10764341
- Menzies D, Alvarez G, Khan K. Treatment of latent tuberculosis infection. In: D. Menzies ed. Canadian Tuberculosis Standards. 7th ed. Ottawa, Canada: Public Health Agency of Canada; Canadian Thoracic Society; 2014, Chp 6.
- Getahun H, Matteelli A, Chaisson RE, Reviglione M. Latent mycobacterial tuberculosis infection. N Eng J Med. 2015;372(22):2127–35. doi:10.1056/NEJMra1405427.
- WHO. Towards TB Elimination: An action framework for low-incidence countries, 2014. at http://apps.who.int/iris/bistreatm/10665/132231/1/9789241507707_eng.pdf. Accessed April 24, 2017.
- FNIHB. Health Canada's monitoring and performance framework for Tuberculosis Programs for First Nations on Reserve. 2015. at https://www.canada.ca/en/health-canada/services/publications/science-research-data/monitoring-performance-framework-tuberculosis-programs-first-nations-reserve-2015.html. Accessed April 24, 2017.
- Reeves R, Daly CL. Screening for latent tuberculosis infection. JAMA Intern Med. 2016;176(10):1439–40. doi:10.1001/jamainternmed.2016.5464. PMID:27599130
- WHO. Global strategy and targets for tuberculosis prevention, care, and control after 2015. WHO website. http://www.who.int/tb/post2015_strategy/en/. Accessed November 15, 2016.
- Saskatchewan Provincial Tuberculosis Strategy 2013–2018: Prevention, Education, and Control. 2013. Saskatchewan Health Website. https://www.saskatchewan.ca/government/health-care-administration-and-provider-resources/sasktchewan-health-initiatives/provincial-tuberculosis-strategy. Accessed February 6, 2017.
- Porter ME. A strategy for health care reform – toward a value-based system. N Eng J Med. 2009;361:109–12. doi:10.1056/NEJMp0904131.
- Brown MM, Brown GC, Sharma S, Landy J. Health care economic analysis and value-based medicine. Survey of Ophthal. 2003;48:204–23. doi:10.1016/S0039-6257(02)00457-5.
- Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003;7:556–62. PMID:12797698
- Public Health Agency of Canada. Tuberculosis in Canada, 2013 Annual Report. PHAC website. www.phac-aspc.gc.ca/tbpc-latb/pubs/tbcan13pre/assets/pdf/tbcan13pre-eng.pdf. Accessed November 15, 2016.
- Menzies D, Oxlade O, Lewis M. Costs for tuberculosis care in Canada. Can J Pub Health. 2008;99:391–6.
- Holland DP, Sanders GD, Hamilton CD, Stout JE. Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med. 2009;179(11):1055–60. doi:10.1164/rccm.200901-0153OC. PMID:19299495
- Public Health Agency of Canada. Appendix B, Canadian tuberculosis surveillance systems. In: D. Menzies ed. Canadian Tuberculosis Standards, 7th Ed. Ottawa, Canada: Public Health Agency of Canada; 2014, p. 425.
- Rothman K, Greenland S, Lash TL. Modern Epidemiology, 3rd ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams and Wilkins; 2008.
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn. 1958;53(282):457–81. doi:10.1080/01621459.1958.10501452.
- Therneau T, Grambsh P. Modeling survival data: extending the Cox Model. New York, NY: Springer Verlag; 2000.
- Bank of Canada Consumer Price Index. Bank of Canada Website. http://www.bankofcanada.ca/rates/related/inflation-calculator/. Accessed November 16, 2016.
- Wobeser W, To T, Hoeppner VH. The outcome of chemoprophylaxis on tuberculosis prevention in the canadian plains indian. Clin Invest Med. 1989;12:149–153. PMID:2743632
- WHO. Guidelines on the management of latent tuberculosis infection. 2015. WHO website. http://www.who.int/tb/publications/ltbi_document_page/en/. Accessed November 18, 2016.
- Rivest P, Street M-C, Allard R. Completion rates of treatment for latent tuberculosis infection. Can J Public Health. 2013;104(3):e235–e239. doi:10.17269/cjph.104.3643. PMID:23823888
- McNab BD, Marciniuk DD, Alvi RA, Tan L, Hoeppner VH. Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian Plains Aborigines. Am J Resp Crit Care Med. 2000;162:989–93. doi:10.1164/ajrccm.162.3.9804117. PMID:10988118
- Saskatchewan Health. Annual Reports Saskatchewan Tuberculosis and Prevention Program; 1986, 2001, 2011 (Available on request).
- Public Health Agency of Canada. Tuberculosis in Canada; 1986 (Available on request); 2001, 2014. at http://publications.gc.ca/collections/Collection/H49-108-2001E.pdf. Accessed on line April 27, 2017.
- Oxlade O, Schwartzman K, Behr MA, et al. Global tuberculosis trends: a reflection of changes in tuberculosis control or in population health? In J Tuberc Lung Dis. 2009;13(10):1238–46.
- Jensen M, Lau A, Langlois-Klassen D, Boffa J, Manfreda J, Long R. A population-based study of tuberculosis epidemiology and innovative service delivery in Canada. Int J Tuberc Lung Dis. 2012;16(1):43–9. doi:10.5588/ijtld.11.0374. PMID:22236844
- Public Health Agency Canada. Tuberculosis prevention and control in Canada: a federal framework for action. at http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tpc-pct/assets/pdf/tpc-pcta-eng.pdf. Accessed November 18, 2016.
- Health Canada. Strategy against tuberculosis for First Nations on-reserve. 2012. at http://publications.gc.ca/collections/collection_2012/sc-hc/H34-245-2012-eng.pdf. Accessed on April 27, 2017
- WHO. Global tuberculosis report. 2012. http:/apps.who.int/iris/bitstream/10665/75938/9789241564502_eng.pdf. Accessed April 27, 2017.
- Sterling TR, Villarino E, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365(23):2155–66. doi:10.1056/NEJMoa1104875. PMID:22150035
- IUAT Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull WHO. 1982;60:555–64. PMID:6754120
- Kitai I, Demers AM. Pediatric Tuberculosis. In: D. Menzies ed. Canadian Tuberculosis Standards, 7th Ed. Ottawa, Canada: Public Health Agency of Canada; Canadian Thoracic Society; 2014, Chp 9.
- Ward HA, Marciniuk DD, Pahwa P, Hoeppner VH. Extent of pulmonary tuberculosis in patients diagnosed by active compared to passive case finding. Int J Tuberc Lung Dis 2004;8(5):593–7. PMID:15137536
- Seddon JA, Jenkins HE, Liu L, et al. Counting children with tuberculosis: why numbers matter. Int J Tuberc Lung Dis. 2015;10(1):9–16. doi:10.5588/ijtld.15.0471.
- Eamranond P, Jarmillo E. Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis. 2001;5(7):594–603. PMID:11467365
- Neu N, Saiman L, Gabriel P, et al. Diagnosis of pediatric tuberculosis in the modern era. Ped Infe Dis J. 1999;18(2):122–6. doi:10.1097/00006454-199902000-00008.
- Fine PEM. Variation in protection of BCG: implications of and for heterologous immunity. Lancet. 1995;346:1339–45. doi:10.1016/S0140-6736(95)92348-9. PMID:7475776
- Reid JK, Ward HA, Marciniuk D, Hudson S, Smith P, Hoeppner VH. The effect of neonatal Bacille Calmette-Guerin vaccination on purified protein derivative skin test results in Canadian aboriginal children. Chest. 2007;131:1806–10. doi:10.1378/chest.06-1133. PMID:17400666
- Mor Z, Migliori GB, Althomsons SP, Loddenkemper R, Trnka L, Iademarco MF. Comparison of tuberculosis surveillance systems in low-incidence industrialized countries. Eur Respir J. 2008;32:161–24. doi:10.1183/09031936.00042908.